remark
increas
preval
asthma
allerg
diseas
affluent
societi
last
decad
particularli
affect
children
asthma
affect
million
peopl
worldwid
cost
tuberculosi
aid
combin
doubt
genet
environment
factor
influenc
develop
asthma
acut
exacerb
diseas
account
morbid
patient
discomfort
cost
trigger
environment
stimuli
includ
allergen
pollut
viral
infect
associ
common
cold
asthma
episod
certainli
old
one
howev
recent
lack
sensit
methodolog
detect
preval
respiratori
virus
rhinovirus
rv
coronavirus
make
difficult
evalu
import
advent
polymeras
chain
reaction
pcr
shown
major
asthma
exacerb
follow
virolog
confirm
upper
respiratori
tract
infect
due
rv
impli
understand
rvinduc
asthma
mechan
could
offer
import
evid
pathogenesi
diseas
well
novel
therapeut
target
initi
epidemiolog
studi
confirm
sever
instanc
percentag
virusrel
wheez
children
usual
adult
proport
vari
case
conclus
epidemiolog
studi
rv
respons
major
common
cold
also
least
half
acut
asthma
exacerb
commun
crucial
understand
rvassoci
asthma
exacerb
debat
whether
exacerb
result
direct
infect
lower
airway
epithelium
rv
indirect
mechan
due
paediatr
respiratori
review
summari
sever
epidemiolog
studi
use
sensit
detect
methodolog
confirm
major
acut
asthma
exacerb
follow
upper
respiratori
tract
infect
common
cold
cold
due
human
rhinovirus
rv
rv
abl
reach
replic
epitheli
cell
lower
airway
activ
cell
produc
proinflammatori
mediat
circumst
rv
also
becom
cytotox
epithelium
atop
asthmat
individu
produc
less
interferong
normal
subject
respons
rv
infect
symptom
sever
well
viral
shed
experiment
rv
infect
invers
correl
atop
statu
express
interferong
ratio
express
costimulatori
molecul
immun
cell
also
affect
atop
asthmat
suggest
aberr
immun
respons
rv
may
lead
suboptim
viral
clearanc
viral
persist
effect
revers
vitro
corticosteroid
secondgener
antihistamin
antioxid
howev
optim
strategi
treat
acut
asthma
exacerb
requir
research
mechanist
clinic
level
elsevi
ltd
right
reserv
infect
upper
airway
alon
resolut
problem
could
reveal
initi
event
pathway
lead
upper
respiratori
viral
infect
asthma
exacerb
suggest
whether
opportun
act
therapeut
asthma
antivir
therapi
sinc
immunolog
defect
express
imbal
type
interferong
interleukin
il
type
etc
cytokin
central
characterist
atopi
asthma
would
consider
import
evalu
immun
respons
rv
infect
atop
asthmat
popul
especi
relat
ongo
debat
potenti
anoth
respiratori
viru
respiratori
syncyti
viru
rsv
deviat
immun
earli
age
thu
initi
asthma
immun
deviat
present
could
help
explain
appar
paradox
induct
asthma
paradigm
diseas
stimulu
viral
infect
last
year
increas
number
invitro
invivo
studi
perform
order
address
question
review
present
current
evid
attempt
identifi
piec
puzzl
still
discov
abil
rv
infect
human
bronchi
long
disput
one
frequent
quot
argument
possibl
temperatur
restrict
replic
virus
optimum
temperatur
nasal
caviti
nevertheless
dogma
base
small
number
studi
use
one
rv
serotyp
therefor
cultur
differ
rv
serotyp
compar
replic
capac
use
titrat
assay
although
prefer
sever
serotyp
differ
small
viru
titr
achiev
high
furthermor
wildtyp
rv
isol
compar
less
half
replic
better
one
isol
prefer
consequ
conclud
temperatur
restrict
rv
replic
lower
airway
abil
rv
infect
human
bronchial
epitheli
cell
initi
demonstr
use
transform
continu
cell
line
subsequ
studi
bronchial
epithelium
model
use
primari
cell
deriv
surgic
resect
materi
monolay
cell
expos
differ
rv
timedepend
increas
viral
rna
assess
rvspecif
pcr
observ
well
increas
viral
titr
peak
viral
replic
h
h
follow
slow
gradual
declin
live
viru
remain
bronchial
epitheli
cell
long
day
exposur
use
immunoprecipit
radiolabel
newli
synthesis
protein
specif
antibodi
shown
newli
synthesis
rv
protein
present
h
exposur
infect
kinet
similar
report
nasal
tracheal
epithelium
suggest
whole
respiratori
tree
equal
suscept
rv
result
almost
ident
find
anoth
group
also
reproduc
murin
epitheli
cell
use
either
minor
subtyp
rv
whose
receptor
present
cell
major
subtyp
cell
transfect
intercellular
adhes
receptor
major
subgroup
rv
unexpect
find
exposur
spars
seed
monolay
primari
bronchial
cell
higher
concentr
viru
infecti
unitscel
result
consider
rvspecif
cytopath
effect
also
case
studi
schroth
et
al
howev
author
observ
variat
cytotox
abil
differ
rv
serotyp
propos
serotyp
may
import
determin
rvinduc
cytotox
observ
contrast
previou
data
show
lack
rv
cytopath
effect
sever
epitheli
cell
model
suggest
specif
condit
appli
rv
becom
cytotox
previou
studi
shown
invivo
rv
infect
produc
littl
histolog
alter
patchi
distribut
respiratori
epithelium
also
case
recent
studi
mosser
et
al
investig
rv
infect
adenoid
tissu
studi
found
small
proport
cell
infect
neglig
epitheli
cytotox
howev
specul
alreadi
disrupt
epithelium
case
asthma
may
suscept
rvinduc
cytotox
reason
assess
rvassoci
cytotox
cell
seed
vari
densiti
use
panel
differ
rv
cytotox
vari
serotyp
also
depend
upon
cell
densiti
almost
linear
way
confluenc
studi
characteris
phenomenon
underway
conclus
evid
rv
replic
lung
obtain
bronchial
biopsi
human
volunt
experiment
expos
rv
develop
cold
previou
attempt
investig
hypothesi
bronchial
rv
infect
hamper
possibl
contamin
upper
airway
sampl
howev
shown
rv
genet
materi
present
higher
quantiti
cell
bronchoalveolar
lavag
rather
supernat
suggest
intracellular
presenc
use
insitu
hybridis
preclud
possibl
contamin
probe
either
genom
replic
strand
viru
shown
bronchial
biopsi
infect
volunt
contain
rv
rna
experiment
induc
cold
mostli
epitheli
layer
sampl
posit
genom
replic
strand
probe
hybridis
signal
colocalis
indic
rv
reach
enter
bronchial
epithelium
upper
airway
infect
also
replic
percentag
posit
ident
report
studi
use
techniqu
nasal
epithelium
rv
presenc
disput
indic
rv
bronchial
infect
may
norm
rather
except
common
cold
similar
rv
infect
rate
upper
lower
epithelium
recent
confirm
ex
vivo
remain
confirm
whether
bronchial
rv
infect
also
take
place
natur
cold
actual
proport
upper
airway
infect
follow
bronchial
spread
viru
also
need
assess
evid
strongli
support
hypothesi
rv
infect
bronchial
epithelium
initi
pathogen
event
rvinduc
asthma
exacerb
determin
whether
rv
bronchial
infect
result
local
inflamm
proinflammatori
cytokin
chemokin
result
natur
infect
experiment
infect
vitro
measur
differ
set
primari
cell
infect
rv
express
mrna
produc
rant
cell
eosinophilspecif
chemoattract
eotaxin
also
induc
upper
airway
eotaxin
found
elev
experiment
cold
subject
allerg
rhiniti
agreement
result
subject
natur
acquir
cold
show
prolong
eosinophil
influx
nasal
mucosa
persist
convalesc
allerg
subject
central
mediat
inflamm
neutrophil
recruit
respect
also
found
rv
infect
upper
respiratori
epithelium
andor
nasal
secret
interestingli
high
level
nasal
fluid
increas
allergeninduc
plasma
exud
respons
observ
allerg
subject
inocul
protect
develop
cold
symptom
proinflammatori
cytokin
produc
increas
level
nasal
secret
experiment
infect
volunt
wherea
elev
nasal
granulocytecoloni
stimul
factor
level
correl
neutrophilia
blood
nasal
secret
follow
challeng
subject
allerg
rhiniti
asthma
children
viralprecipit
asthma
rant
potent
eosinophil
neutrophil
chemoattract
seem
key
compon
rvmediat
inflamm
invitro
invivo
studi
rv
also
stimul
product
angiogen
growth
factor
fibroblast
growth
bronchial
epitheli
cell
may
act
underli
stromal
cell
induc
tissu
remodel
import
compon
allerg
inflamm
notabl
also
receptor
rv
rv
abl
upregul
receptor
nuclear
factorkappa
b
nfkb
depend
mechan
suggest
might
strategi
enhanc
infect
virus
transcript
abovement
mediat
also
promot
nfkb
indic
common
molecular
pathway
may
regul
rvinduc
inflamm
well
repres
import
therapeut
target
furthermor
upregul
inhibit
corticosteroid
secondgener
antihistamin
reduc
agent
potenti
treatment
virusassoci
wheez
hallmark
pathophysiolog
asthma
imbal
two
type
polaris
immun
respons
initi
demonstr
thelper
cell
subsequ
shown
involv
cytotox
cell
probabl
dendrit
cell
well
ifng
central
cytokin
type
respons
type
respons
characteris
increas
array
cytokin
chemokin
known
take
part
influenc
balanc
asthma
paradigm
type
cytokinerel
diseas
evid
suggest
antivir
immun
respons
usual
domin
type
cytokin
order
model
possibl
effect
rv
infect
atop
asthma
use
peripher
blood
mononuclear
cell
pbmc
deriv
normal
atop
asthmat
subject
expos
rv
assess
type
type
cytokin
product
pbmc
expos
rv
timeand
dosedepend
increas
ifng
observ
ifng
concentr
significantli
higher
cell
normal
individu
predomin
cultur
atop
asthmat
subject
furthermor
induc
cultur
asthmat
subject
induct
found
normal
atop
asthmat
subject
data
suggest
follow
bronchial
epitheli
infect
rv
concomit
inflammatori
respons
describ
system
immun
respons
known
occur
vivo
common
cold
probabl
defect
atop
asthmat
individu
decreas
level
type
cytokin
increas
level
type
cytokin
express
threefold
differ
ratio
normal
atop
individu
experi
support
notion
suboptim
antivir
respons
may
enhanc
alreadi
type
environ
occur
asthma
data
agreement
recent
evid
parri
et
al
show
invers
correl
ifng
product
pbmc
experiment
induc
infect
rv
shed
infect
anoth
studi
demonstr
invers
correl
rv
persist
symptom
score
experiment
infect
ratio
level
nasal
secret
even
interest
evid
group
show
invers
correl
pbmc
ifng
respons
virusinduc
airway
hyperreact
patient
asthma
take
data
consider
hypothesis
rv
may
induc
phenotyp
chang
immun
cell
pbmc
expos
rv
vitro
phenotyp
flow
cytometri
sever
alter
observ
surprisingli
cell
activ
indic
increas
express
agreement
previou
report
chang
number
cell
posit
b
cell
cultur
number
monocyt
reduc
rv
infect
pronounc
cell
normal
subject
compar
asthmat
subject
furthermor
induc
monocyt
b
cell
upregul
less
mark
asthmat
popul
final
consid
neg
regul
costimulatori
system
upregul
cell
asthmat
patient
alon
data
confirm
abil
rv
activ
antigen
present
system
also
shown
respiratori
epitheli
cell
also
indic
process
defect
atop
asthmat
subject
defect
antigen
present
may
partli
explain
delay
viral
clearanc
increas
symptomatolog
observ
experiment
infect
studi
mechan
rvinduc
asthma
exacerb
great
import
understand
childhood
asthma
rv
common
respiratori
pathogen
respons
major
asthma
exacerb
childhood
therapeut
strategi
aim
virus
andor
inflammatori
consequ
potenti
greatli
allevi
morbid
cost
asthma
sever
question
still
answer
order
design
effect
therapi
nevertheless
piec
puzzl
seem
get
closer
togeth
know
bronchial
infect
frequent
develop
subsequ
common
cold
infect
abl
induc
epitheli
inflammatori
respons
among
other
lead
bronchial
cellular
infiltr
demonstr
experiment
rv
infect
probabl
relat
develop
asthma
exacerb
symptomatolog
respect
necessari
determin
whether
window
opportun
exist
introduct
specif
antirhinovir
drug
potenti
therapi
prevent
acut
asthma
exacerb
moreov
atop
asthmat
individu
demonstr
defect
invitro
antivir
immun
respons
consist
understand
aberr
immun
ubiquit
environment
antigen
allergen
therefor
possibl
rv
infect
individu
initi
amplifi
immunemedi
type
inflamm
characteris
pathophysiolog
asthma
anim
model
rv
infect
current
exist
addit
human
studi
requir
explor
observ
common
cold
frequent
trigger
acut
asthma
exacerb
children
adult
human
rv
respons
major
common
cold
rv
abl
reach
replic
bronchial
epithelium
healthi
asthmat
individu
epitheli
rv
infect
induc
product
mani
proinflammatori
mediat
includ
rant
eotaxin
upregul
receptor
rv
immun
respons
rv
affect
atop
statu
host
vitro
vivo
seem
regul
viral
shed
symptom
